The Straight Dose.Get the emails

Rabbit hole 02

Peptides

The full 3 part series, sourced and in plain English. Want it in your inbox instead? Sign up here.

Part 1 of 3

the peptide rules just got weird

You picked peptides. Buckle up.

A peptide is just a short chain of amino acids. GLP-1 is one. So are dozens of compounds you've seen all over social media.

Here's the part nobody explains. A compounding pharmacy can only make a medicine from a raw ingredient the FDA allows. In 2023 the FDA flagged several popular peptides, including BPC-157 and TB-500, as raising significant safety concerns for compounding.

In July 2026 an FDA advisory committee voted to recommend six of them, BPC-157 included, for the compounding list. But that vote is advice, not a rule. Until the FDA finishes formal rulemaking, expected into 2027, they are still not on the list.

Translation: if someone online is selling you "research peptides" with no prescriber and no licensed pharmacy, that's the red flag.

Sources: FDA Category 2 list · Buchanan on the July 2026 PCAC votes

Part 2 of 3

which peptides actually have human evidence?

Last time: the rules. Today: the evidence.

Some peptides are fully approved medicines with large human trials behind them. GLP-1 drugs and insulin are both peptides.

Then there's the social media crowd. Take BPC-157, the most hyped one. A 2025 systematic review in the HSS Journal looked at 36 studies. 35 were in animals or lab dishes. One was in humans: 7 of 12 people with chronic knee pain reported relief after a single injection. No control group.

A second 2025 review concluded BPC-157 should be considered investigational until real human trials are done. It's also been banned in sport by WADA since 2022.

Our rule of thumb: when someone says "studies show," ask how many were in people.

Sources: BPC-157 systematic review, HSS Journal 2025 · BPC-157 narrative review, 2025

Part 3 of 3

the "research use only" trick

You've probably seen it: a site selling peptides with "for research use only, not for human consumption" in small print, right next to a dosing chart.

The FDA isn't buying it. In warning letters to online peptide sellers, the agency said that when a website shows the product is meant for people, the label doesn't change anything: it's an unapproved drug.

And quality is a coin flip. The Institute for Safe Medication Practices reported in 2026 that tests of peptides sold online found some with purity as low as 5 percent.

Red flags: no prescription needed, no licensed pharmacy named, "not for human use" next to dosing advice, ships from overseas.

What legit looks like: a licensed prescriber who reviews your history, and a state licensed pharmacy filling it.

Questions? Hit reply.

Sources: ISMP: wellness peptides sold online (2026) · FDA warning letters to peptide sellers

Send me the next topic